CLBS Insider Trading Activity and SEC Form 4 Filings
CLBS insider trading summary
No open-market insider purchases or sales of Caladrius Biosciences, Inc. (CLBS) have been reported on SEC Form 4 in the past 12 months.
Latest CLBS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 8, 2021 | Steven S Myers | Director | Buy | $30K (33,785 @ $0.89) |
| Sep 9, 2020 | Michael H. Davidson | Director | Buy | $100K (55,525 @ $1.80) |
| Feb 7, 2017 | Eric Wei | Director | Sell | $31K (6,575 @ $4.77) |
| Feb 6, 2017 | Eric Wei | Director | Sell | $2K (500 @ $4.75) |
| Feb 3, 2017 | Eric Wei | Director | Sell | $7K (1,525 @ $4.76) |
| Feb 2, 2017 | Eric Wei | Director | Sell | $7K (1,400 @ $4.75) |
| Feb 2, 2017 | Eric Wei | Director | Sell | $23K (5,000 @ $4.51) |
| Nov 21, 2016 | Eric Wei | Director | Sell | $2K (500 @ $4.20) |
| Jul 1, 2016 | Eric Wei | Director | Sell | $10K (16,094 @ $0.61) |
| Jun 30, 2016 | Eric Wei | Director | Sell | $43K (71,406 @ $0.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.